Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
236
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
+44.5M
-
Total reported value, excl. options
-
$328M
-
Value change
-
+$117M
-
Put/Call ratio
-
1.26
-
Number of buys
-
162
-
Number of sells
-
-59
-
Price
-
$2.64
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q2 2025
281 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q2 2025.
ImmunityBio, Inc. - COM (IBRX) has 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (21.8M shares), BlackRock, Inc. (17.8M shares), BANK OF AMERICA CORP /DE/ (8.76M shares), ARMISTICE CAPITAL, LLC (7.76M shares), JANE STREET GROUP, LLC (7.72M shares), STATE STREET CORP (7.62M shares), GEODE CAPITAL MANAGEMENT, LLC (5.78M shares), Woodline Partners LP (3.45M shares), MILLENNIUM MANAGEMENT LLC (3.24M shares), and AlphaCore Capital LLC (2.97M shares).
This table shows the top 236 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.